AcquisitionOther
Galecto, Inc. acquired Damora Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Galecto, Inc. -> Damora Therapeutics, Inc. · Acquisition + $284.9 million private placement
Combining complementary assets with Damora to advance portfolio covering broad spectrum of hematological cancers with safer and more effective therapies.
Open source record (SEC) ↗